Denizot Y, Dupuis F, Comte L, Dulery C, Praloran V
Laboratoire d'Hématologie Expérimentale Faculté de Médecine, Limoges, France.
Cancer Lett. 1995 Jan 27;88(2):185-9. doi: 10.1016/0304-3835(94)03631-r.
The spleen and thymus of mice were examined for the presence of PAF after injection of 5-fluorouracil (5-FU) (200 mg/kg). A significant increase of the spleen (P = 0.005) and thymus (P < 0.05) PAF concentrations was noted 48 h after 5-FU infusion. PAF levels in thymus are similar to those of controls from days 4 to 14. By contrast, spleen PAF significantly decreased (0.005 < P < 0.03) from days 7 to 14. Conversely, the 5-FU administration did not modify the spleen and plasma acetylhydrolase activity, suggesting that the variations of PAF levels in thymus and spleen were mainly due to differences of local PAF production. Thus, the chemotherapeutic drug 5-FU modulates in vivo PAF production in haematopoietic organs of mice. Considering the effects of PAF in the processes of B- and T-cell proliferation and functions, these results could be of importance for the role of PAF during human cancer therapy and haematopoiesis in vivo.
给小鼠注射5-氟尿嘧啶(5-FU,200mg/kg)后,检测其脾脏和胸腺中血小板活化因子(PAF)的存在情况。在输注5-FU后48小时,脾脏(P = 0.005)和胸腺(P < 0.05)中的PAF浓度显著升高。从第4天到第14天,胸腺中的PAF水平与对照组相似。相比之下,从第7天到第14天,脾脏中的PAF显著降低(0.005 < P < 0.03)。相反,5-FU给药并未改变脾脏和血浆中的乙酰水解酶活性,这表明胸腺和脾脏中PAF水平的变化主要是由于局部PAF产生的差异。因此,化疗药物5-FU可调节小鼠造血器官中体内PAF的产生。考虑到PAF在B细胞和T细胞增殖及功能过程中的作用,这些结果对于PAF在人类癌症治疗和体内造血过程中的作用可能具有重要意义。